NEUROPSYCHOLOGICAL ASPECTS OF CHRONIC DAILY HEADACHES AND COGNITIVE DECLINE: DATA FROM A COHORT STUDY
Keywords:
Personalized therapy, chronic daily headaches, genetic markers, vascular markers, individualized treatment, pathogenesis, quality of life.Abstract
The article discusses personalized therapy of chronic daily headaches with a focus on the role of genetic and vascular markers. It analyzes the mechanisms of influence of hereditary factors and vascular system characteristics on the pathogenesis of the disease and treatment effectiveness. It is emphasized that considering these markers makes it possible to develop individualized therapeutic schemes, which increase treatment efficacy and minimize side effects. Particular attention is given to the prospects of applying a personalized approach to improve patients’ quality of life.
References
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Lipton RB. Chronic migraine prevalence, disability, and sociodemographic factors. Headache. 2012;52(10):1456-1470.
Chong CD, Schwedt TJ. Migraine affects white matter tract integrity: a diffusion-tensor imaging study. Cephalalgia. 2015;35(13):1162-1171.
Verhagen AP, Damen L, Berger MY, et al. Prognosis of chronic daily headache in primary care. J Headache Pain. 2010;11(3):151-158.
Grazzi L, Raggi A. Cognitive and psychological features in patients with chronic migraine. Neurol Sci. 2020;41(Suppl 2):477-480.
Olesen J, et al. The burden of migraine and tension-type headache. Curr Opin Neurol. 2022;35(3):281-287.
